Abstract:Objective To elucidate the important role and molecular mechanism of AT1R/miR-26a pathway in hypertensive vascular remodeling. Methods ① Eight-week-old male spontaneously hypertensive rats (SHRs) were randomly divided into losartan group [gavage with losartan 20 mg/(kg·d) for 8 weeks], prazosin group [gavage with prazosin 5 mg/(kg·d) for 8 weeks], SHR control group [gavage with pure water 10 mL/(kg·d) for 8 weeks], with 8 animals in each groups. Six eight-week-old male WKY rats served as normal control group [gavage with pure water 10 mL/(kg·d) for 8 weeks]. All rats in each group were measured for systolic blood pressure (SBP) through tail artery in 3 to 5 d before and during the intervention period until the end of treatment. ② After the rats were anesthetized, the thoracic aorta were harvested for detecting the expression level of miR-26a by real-time quantitative polymerase chain reaction (qPCR). ③ The thoracic aorta was embedded in paraffin, and sectioned for HE and Masson staining, α-actin and PCNA immunohistochemistry. ④ The expression of AT1R, TGFβ1, p-smad3 and CTGF in the thoracic aorta were detected by Western blotting. ⑤ The rat thoracic aortic smooth muscle cells (VSMCs) at 3 to 9 passages were divided into AngⅡ treatment group (VSMCs+AngⅡ, AngⅡ10-7 mol/L, treated for 24 h), and control group (VSMC+Ctrl). qPCR was used to detect the expression level of miR-26a, and the expression of smad3 and p-smad3 was observed by Western blotting. Results ① At the end of treatment received, SBP was significantly lower in the losartan and prazosin groups than the SHR control group, but all of them were obviously higher than that of normal control group (P < 0.05). There was no significant difference in SBP between the losartan and prazosin groups (P>0.05). ②The expression of miR-26a in the thoracic aorta was notably higher in the losartan and prazosin groups than the SHR control group, but statistically lower than the normal control group (P < 0.05), and that of the losartan group was higher than that of the prazosin group (P < 0.05). ③ Media thickness/lumen diameter (MT/LD), collagen volume fraction (CVF), and smooth muscle cell proliferation index in the losartan and prazosin groups were remarkably lower than those in the SHR control group (P < 0.05), and those in the losartan group were lower than those of the prazosin group. The normal control group had no obvious thickening of the vascular wall, with well-arranged smooth muscle cells, and regular morphology of the nucleus, and no significant collagen fiber deposition. ④The expression levels of AT1R, p-smad3, TGFβ1 and CTGF in the thoracic aorta were significantly lower in the losartan and prazosin groups than the SHR control group (P < 0.05). Although those in the losartan group were lower than those of the prazosin group (P < 0.05), the levels in the both group were higher than those of normal control group (P < 0.05). ⑤The expression of miR-26a was significantly lower, and that of p-smad3 was higher in VSMC+AngⅡ group when compared with VSMC+Ctrl group (P < 0.05). Conclusion miR-26a prevents blood pressure from rising and has a protective effect in the process of hypertensive vascular remodeling. Blocking AT1 receptor may improve the remodeling by up-regulating miR-26a.

Comparative analysis of relative gene expression data reveals novel microRNAs in the artery of rats with renovascular hypertension

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

Abstract 050: mir-192-5p in the Kidney is Protective Against the Development of Hypertension

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

Abstract P125: RNA Sequencing of Left-ventricular Tissue Highlights Novel Pathways Impacted by the Loss of Mir-146B-5p in a Rat Model of Chronic Kidney Disease

Transcriptome Analysis of Arterial and Venous Circulating Mirnas During Hypertension

MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension.

[Differential expression of microRNAs in the aorta of spontaneously hypertensive rats]

Differential Microrna Expression Profiles and Bioinformatics Analysis Between Young and Aging Spontaneously Hypertensive Rats

Abstract 059: Mir-29 is Required for Normal Endothelium-dependent Vasodilation and Protects Against Hypertension

Profiles of Long Noncoding RNAs in Hypertensive Rats

Differential Expression of Microrna in the Lungs of Rats with Pulmonary Arterial Hypertension

Regulation Mechanism of AT1R/miR-26a Pathway in Hypertensive Vascular Remodeling

Analysis of microRNA expression in rat kidneys after VEGF inhibitor treatment under different degrees of hypoxia

MiR-3571 modulates the proliferation and migration of vascular smooth muscle cells by targeting claudin 1

Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension

Identification and characteristics of microRNAs with altered expression patterns in a rat model of abdominal aortic aneurysms.

Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension

Single-cell RNA sequencing reveals cell type- and artery type-specific vascular remodelling in male spontaneously hypertensive rats

Role of miR-145 expression in arterial intimal hyperplasia of hypertension in rats

MiR-34a ameliorates arterial blood flow in rats with lower limb arteriosclerosis obliterans via Sirt1 signaling pathway